When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BridgeBio (BBIO) has filed to raise gross proceeds of up to $225 million from a U.S. IPO, according to an S-1/A registration statement.
The group is developing therapeutics for Mendelian diseases, or diseases arising from defects in a single gene as well as cancers with clear genetic drivers.
BBIO is pursuing a very broad and diverse set of treatment programs and is asking for a high IPO valuation.
Company & Technology
Palo Alto, California-based BridgeBio was founded in 2015 to develop therapeutics for patients suffering from Mendelian diseases or cancers